Drug Shortage Report for AURO-LOSARTAN HCT
Report ID | 97195 |
Drug Identification Number | 02423650 |
Brand name | AURO-LOSARTAN HCT |
Common or Proper name | Hydrochlorothiazide; Losartan Potassium |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
Strength(s) | 12.5MG 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 & 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-10-23 |
Estimated end date | 2021-07-14 |
Actual end date | 2021-05-20 |
Shortage status | Resolved |
Updated date | 2021-07-12 |
Company comments | Auro-Losartan HCT 100/12.5mg Tab 100 Btl is available. Auro-Losartan HCT 100/12.5mg Tab (30's) Btl is discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.